The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment

Published:2023-02 Issue: Volume:70 Page:104497
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Pham H. Phuong T.,Saroukhani Sepideh,Lindsey J. William^ORCID

Funder

Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston

Genentech

Health Science Center, University of North Texas

National Center for Advancing Translational Sciences

Center for Clinical and Translational Science, University of Illinois at Chicago

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference14 articles.

1. Duration of humoral immunity to common viral and vaccine antigens;Amanna;N. Engl. J. Med.,2007

2. Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies;Bar-Or;Trends Mol. Med.,2020

3. The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: a hypothesis;Berger;Mult. Scler. Relat. Disord.,2022

4. The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins;Dooley;J. Neuroimmunol.,2016

5. Ocrelizumab versus interferon Beta-1A in relapsing multiple sclerosis;Hauser;N. Engl. J. Med.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients;Multiple Sclerosis and Related Disorders;2024-06

2. How to and should we target EBV in MS?;Expert Review of Clinical Immunology;2024-03-15

3. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review;Multiple Sclerosis and Related Disorders;2023-12

4. Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients;2023-11-10

5. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy;Multiple Sclerosis and Related Disorders;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3